Catalyst Pharmaceuticals Inc

Healthcare · Biotechnology

31.50$ +0.0% vs. previous close Closing price · As of: Jul 21, 2026

Statements

Balance Sheet

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CPRX
Line item	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26
Total Assets	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%
Current Assets	54.3%	46.5%	46.7%	62.6%	67.2%	69.8%	73.2%	75.4%	78.1%	81.1%	80.8%	81.9%
Cash	40.3%	29.3%	29.3%	48.0%	53.2%	57.3%	60.8%	63.9%	67.2%	65.6%	64.1%	65.9%
Cash & Short-Term Investments	40.3%	29.3%	29.3%	48.0%	53.2%	57.3%	60.8%	63.9%	67.2%	65.6%	64.1%	65.9%
Receivables	9.6%	11.6%	11.4%	9.4%	8.1%	7.5%	7.7%	8.0%	6.8%	10.2%	11.6%	11.4%
Inventory	2.4%	2.2%	3.3%	3.1%	2.6%	2.6%	2.3%	2.2%	1.9%	2.7%	3.4%	3.0%
Property, Plant & Equipment	0.9%	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	39.6%	40.4%	41.3%	28.6%	24.8%	21.5%	18.4%	16.2%	14.2%	12.2%	11.9%	10.6%
Total Liabilities	15.5%	15.6%	17.5%	13.2%	13.8%	14.4%	14.5%	12.6%	11.9%	12.5%	13.8%	11.8%
Current Liabilities	11.8%	14.0%	16.2%	12.3%	13.1%	13.7%	14.2%	12.3%	11.6%	12.2%	13.3%	11.5%
Short-Term Debt	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Accounts Payable	1.0%	1.1%	3.1%	1.6%	1.0%	1.5%	1.9%	1.2%	0.6%	0.9%	1.0%	0.6%
Shareholders' Equity	84.5%	84.4%	82.5%	86.8%	86.2%	85.6%	85.5%	87.4%	88.1%	87.5%	86.2%	88.2%
Retained Earnings	26.4%	20.9%	25.8%	22.4%	26.2%	29.7%	33.5%	37.6%	40.5%	42.5%	42.8%	45.6%
Shares Outstanding	25.6%	25.8%	24.2%	19.1%	17.6%	16.2%	14.8%	14.0%	13.1%	12.1%	11.5%	11.1%

Data as of: July 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?